ArticleNPJ precision oncology2024

CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages.

Silvia Pietrobono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.